.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Cerilliant
Merck
Express Scripts
Cantor Fitzgerald
McKesson
Harvard Business School
Medtronic
Novartis
Daiichi Sankyo

Generated: November 21, 2017

DrugPatentWatch Database Preview

Drug Master Files for: arginine

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
279III8/8/1960GENERAL MILLS INCL-ARGININE MONHYDROCHLORIDE AND L-ARGININE AND L-GLUTAMATE
748III12/10/1963AJINOMOTO CO INCL-ARGININE MONOHYDROCHLORIDE
1274III12/31/1968TANABE SEIYAKU CO LTDL-ARGININE MONOHYDROCHLORIDE
1929III5/9/1972TANABE SEIYAKU CO LTDL-ARGININE BASE
2170III10/24/1973KYOWA HAKKO KOGYO CO LTDL-ARGININE, L-ARGININE MONOHYDROCHLORIDE
2184III10/9/1973PFANSTIEHL LABORATORIES INCL-ARGININE MONOHYDROCHLORIDE
2523III6/23/1975SIGMA F AND D DIV LTDAMINO ACIDS: L-ARGININE, FREE BASE AND L-ARGININE, HYDROCHLORIDE
3914III8/5/1980DEGUSSA AG WERK RADEBEULL-ARGININE
3998III11/10/1980DEGUSSA AG WERK RADEBEULL-ARGININE HCL
5033III5/19/1983DEGUSSA AG WERK RADEBEULL-ARGININE ACETATE AS PRODUCED BY REXIM S.A.DIV DEGUSSA -HAM FRANCE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
Deloitte
McKesson
Fuji
Moodys
Medtronic
Chinese Patent Office
Boehringer Ingelheim
QuintilesIMS
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot